139 related articles for article (PubMed ID: 33383882)
1. The Predictive Role of Prostate-Specific Antigen Changes Following Transurethral Resection of the Prostate for Patients with Localized Prostate Cancer.
Wu CT; Huang YC; Chen WC; Chen MF
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33383882
[TBL] [Abstract][Full Text] [Related]
2. [Prostate cancer development after transurethral resection of the prostate--histopathological studies of radical prostatectomy specimens].
Kanno H; Umemoto S; Izumi K; Hasumi H; Osada Y; Ohta J; Mikata K; Tuchiya F
Nihon Hinyokika Gakkai Zasshi; 2006 May; 97(4):649-59. PubMed ID: 16768146
[TBL] [Abstract][Full Text] [Related]
3. Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) Score as a Predictive Value of Incidental Prostate Cancer for Patients Going for Transurethral Resection of the Prostate (TURP): A Single-Center Study.
Bendari A; Bendari A; Zhong X; Geetha SD; Al-Refai R; Sham S; Mohammed H; Anjali F; Unger P
Cureus; 2024 Apr; 16(4):e57736. PubMed ID: 38716011
[TBL] [Abstract][Full Text] [Related]
4. Could the sextant prostate biopsy be replaced by transurethral resection?
Startsev VY; Pouline I; Gorelov S; Merkulova R
Arch Ital Urol Androl; 2005 Dec; 77(4):194-8. PubMed ID: 16444931
[TBL] [Abstract][Full Text] [Related]
5. [Importance of PSA velocity and PSA density in the prediction of prostate cancer in TURP or open prostatectomy specimen of patients with previous negative prostate biopsy].
Rodríguez Alonso A; González Blanco A; Barbagelata López A; Pita Fernández S; Suárez Pascual G; Bonelli Martín C; Cuerpo Pérez M
Actas Urol Esp; 2008 Sep; 32(8):779-86. PubMed ID: 19013975
[TBL] [Abstract][Full Text] [Related]
6. The role of transurethral resection of the prostate for patients with an elevated prostate-specific antigen.
Cho HJ; Shin SC; Cho JM; Kang JY; Yoo TK
Prostate Int; 2014 Dec; 2(4):196-202. PubMed ID: 25599076
[TBL] [Abstract][Full Text] [Related]
7. Concomitant transrectal ultrasound-guided biopsy and transurethral resection of prostate in patients with urinary retention and elevated serum prostate-specific antigen levels.
Yang TY; Chow YC; Lin WR; Ko MC; Chen M; Chang HK; Hsu JM; Yang S; Lin WC; Chiu AW
J Chin Med Assoc; 2016 Nov; 79(11):605-608. PubMed ID: 27344217
[TBL] [Abstract][Full Text] [Related]
8. Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era.
Jones JS; Follis HW; Johnson JR
Prostate Cancer Prostatic Dis; 2009; 12(1):57-60. PubMed ID: 18379587
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Histopathological Characteristics of Prostate Cancer Patients Taken to Palliative Transurethral Prostate Resection.
Rojas-Manrique JP; Ramírez Ramírez A; Becerra Méndez LM; Ramos Ulloa JG; Riveros C; Varela Ramirez R
Cureus; 2019 Sep; 11(9):e5740. PubMed ID: 31723501
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of serum total and free prostate-specific antigen (PSA) after extended multisite prostate biopsy: Comparison among biopsy, transurethral resection of the prostate (TURP), and biopsy plus TURP.
Hara N; Koike H; Nobushita T; Miyajima N; Kawaguchi M; Nishiyama T; Takahashi K; Hohenfellner R
Urol Oncol; 2010; 28(4):355-9. PubMed ID: 19110451
[TBL] [Abstract][Full Text] [Related]
11. Does transurethral resection of prostate (TURP) affect outcome in patients who subsequently develop prostate cancer?
D'Ambrosio DJ; Ruth K; Horwitz EM; Chen DY; Pollack A; Buyyounouski MK
Urology; 2008 May; 71(5):938-41. PubMed ID: 18279939
[TBL] [Abstract][Full Text] [Related]
12. Altered prostate specific antigen reference range after transurethral resection of the prostate.
Wolff JM; Boekels O; Borchers H; Jakse G; Rohde D
Anticancer Res; 2000; 20(6D):4977-80. PubMed ID: 11326651
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of prostate-specific antigen in the transition zone of the prostate. A characterization following prostatectomy for benign hyperplasia.
Recker F; Kwiatkowski MK; Pettersson K; Piironen T; Lümmen G; Huber A; Tscholl R
Eur Urol; 1998; 33(6):549-55. PubMed ID: 9743696
[TBL] [Abstract][Full Text] [Related]
14. The Management of Patients Diagnosed with Incidental Prostate Cancer: Narrative Review.
Abedi AR; Ghiasy S; Fallah-Karkan M; Rahavian A; Allameh F
Res Rep Urol; 2020; 12():105-109. PubMed ID: 32215268
[TBL] [Abstract][Full Text] [Related]
15. Prostate specific antigen levels following transurethral resection of the prostate.
Fonseca RC; Gomes CM; Meireles EB; Freire GC; Srougi M
Int Braz J Urol; 2008; 34(1):41-8. PubMed ID: 18341720
[TBL] [Abstract][Full Text] [Related]
16. Post-brachytherapy transurethral resection of the prostate in patients with localized prostate cancer.
Flam TA; Peyromaure M; Chauveinc L; Thiounn N; Firmin F; Cosset JM; Bernard D
J Urol; 2004 Jul; 172(1):108-11. PubMed ID: 15201748
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level.
van Renterghem K; Van Koeveringe G; Achten R; Van Kerrebroeck P
Eur Urol; 2007 Sep; 52(3):819-26. PubMed ID: 17418482
[TBL] [Abstract][Full Text] [Related]
18. Prostate specific antigen measurements after minimally invasive surgery of the prostate in men with benign prostatic hypertrophy.
Shingleton WB; Terrell F; Kolski J; May W; Renfroe DL; Fowler JE
Prostate Cancer Prostatic Dis; 2000 Nov; 3(3):200-202. PubMed ID: 12497098
[TBL] [Abstract][Full Text] [Related]
19. Changes in immunohistochemical staining of PSA, PAP, and TURP-27 following irradiation therapy for clinically localized prostate cancer.
Grob BM; Schellhammer PF; Brassil DN; Wright GL
Urology; 1994 Oct; 44(4):525-9. PubMed ID: 7524238
[TBL] [Abstract][Full Text] [Related]
20. [Application value of diagnostic TURP for patients with serum PSA abnormality].
Yuan J; Zhao H; Wu B
Zhonghua Nan Ke Xue; 2013 Nov; 19(11):999-1002. PubMed ID: 24341094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
